Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival.
Howard
R J
RJ
Department of Surgery, University of Florida, Gainesville.
Pfaff
W W
WW
Brunson
M E
ME
Ramos
E L
EL
Peterson
J C
JC
Croker
B P
BP
Scornik
J C
JC
Parris
C J
CJ
Fennell
R S
RS
D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000473:pathology / Q000503:physiopathology*; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors
D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone